Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
422 participants
INTERVENTIONAL
2016-01-01
2016-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care with minimal incentives
Participants in this arm receive usual care from the Pro-Change smoking cessation program, and receive compensation for enrolling and completing a survey at the end of the study.
Minimal incentives
Minimal financial incentives to promote engagement and outcomes in a smoking cessation intervention.
Usual care with BE incentives
Participants in this arm receive usual care from the Pro-Change smoking cessation program, the chance to win money based on their behavior (behavioral economics incentives), and receive compensation for enrolling and completing a survey at the end of the study.
Behavioral economics incentives
Behavioral economics-informed incentives to promote engagement and outcomes in a smoking cessation intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral economics incentives
Behavioral economics-informed incentives to promote engagement and outcomes in a smoking cessation intervention.
Minimal incentives
Minimal financial incentives to promote engagement and outcomes in a smoking cessation intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be 18 years old or over
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Rhode Island Primary Care Physicians Corporation
UNKNOWN
Pro-Change Behavior Systems
OTHER
VAL Health, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Horgan, MBA
Role: PRINCIPAL_INVESTIGATOR
President
Kevin Volpp, MD, PhD
Role: STUDY_DIRECTOR
Scientific Advisory Board
David Asch, MD
Role: STUDY_DIRECTOR
Scientific Advisory Board
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VAL Health
Old Greenwich, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.